Detailed Notes on factors affecting posology
Even so, there is a minority of conditions in which the treatment method of EID utilizing the ICOC chelation protocol involving DF or L1 or their blend will not be possible as a consequence of very low tolerability or harmful Unintended effects for example allergic reactions all through parenteral infusion of DF or toxicity including L1 agranulocyt